Marker Therapeutics Inc (MRKR)

[hanscott]

Ah, ok, wait. I was thinking about tumor size here but your original remark was that the patients would otherwise die in 3 months, which is not correct. The data shows the Mean OS at 8.5 and 11 mo for the chemo they were on. So, we would not expect them to all be dead by now if they did not receive Multi-TAA.

What is impressive is that of the five patients in Arm A who've been treated long enough to make it to the Median OS, four of the five are still alive. And only one patient died before the Median OS so far. Hopefully that trend continues.